Published in Cancer Res on March 15, 2001
Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol (2008) 1.91
Carbon ion radiation inhibits glioma and endothelial cell migration induced by secreted VEGF. PLoS One (2014) 1.52
Significance of heparanase in cancer and inflammation. Cancer Microenviron (2011) 1.46
MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One (2011) 1.27
SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer (2010) 1.26
MicroRNA expression profiles in human cancer cells after ionizing radiation. Radiat Oncol (2011) 1.15
Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (2010) 1.15
A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells. J Neuroinflammation (2009) 1.10
Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies. Br J Cancer (2009) 1.09
Ionizing radiation, ion transports, and radioresistance of cancer cells. Front Physiol (2013) 1.09
Invasion patterns in brain metastases of solid cancers. Neuro Oncol (2013) 1.04
Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. Neoplasia (2011) 1.04
uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo. Int J Oncol (2008) 1.04
Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control. Cell Cycle (2012) 1.04
A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro Oncol (2008) 1.04
Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study. Neurosurgery (2006) 1.03
Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene (2012) 1.02
Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma. PLoS One (2010) 1.02
Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model. Clin Exp Metastasis (2005) 1.00
Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma. Cancer Res (2011) 1.00
Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines. Br J Cancer (2003) 0.98
Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways. BMC Cancer (2011) 0.97
Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness. PLoS One (2013) 0.97
Current concepts in clinical radiation oncology. Radiat Environ Biophys (2013) 0.97
Caspase signalling in the absence of apoptosis drives Jnk-dependent invasion. EMBO Rep (2013) 0.95
Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle (2013) 0.94
Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget (2015) 0.94
Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis. PLoS One (2013) 0.93
Irradiation affects cellular properties and Eph receptor expression in human melanoma cells. Cell Adh Migr (2012) 0.93
EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth. PLoS One (2012) 0.93
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. Int J Clin Oncol (2007) 0.91
Lauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective? Health Phys (2012) 0.90
RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells. Int J Oncol (2009) 0.89
Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells. Transl Oncol (2011) 0.88
Integrin signalling and the cellular response to ionizing radiation. J Mol Histol (2004) 0.87
Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation. J Radiat Res (2014) 0.86
Radiation-enhancement of MDA-MB-231 breast cancer cell invasion prevented by a cyclooxygenase-2 inhibitor. Br J Cancer (2011) 0.86
Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling. PLoS One (2013) 0.86
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci (2015) 0.86
Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells. Int J Oncol (2006) 0.85
siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma. Mol Cancer Res (2010) 0.85
Targeting ανβ3 and ανβ5 inhibits photon-induced hypermigration of malignant glioma cells. Radiat Oncol (2011) 0.84
The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway. J Cell Commun Signal (2010) 0.84
Radiation-induced tumor neoantigens: imaging and therapeutic implications. Am J Cancer Res (2011) 0.84
Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer (2014) 0.83
Recruitment of circulating breast cancer cells is stimulated by radiotherapy. Cell Rep (2014) 0.83
DIPG in Children - What Can We Learn from the Past? Front Oncol (2015) 0.83
Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway. BMC Cancer (2015) 0.83
Radiation-induced motility alterations in medulloblastoma cells. J Radiat Res (2015) 0.82
α3β1 integrin promotes radiation-induced migration of meningioma cells. Int J Oncol (2011) 0.82
In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells. Br J Cancer (2007) 0.82
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities. Onco Targets Ther (2013) 0.81
Radiosurgery for high-grade glioma. Surg Neurol Int (2012) 0.81
Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin. Radiol Oncol (2012) 0.80
Carbon ion irradiation of the human prostate cancer cell line PC3: a whole genome microarray study. Int J Oncol (2014) 0.80
Management of high-grade gliomas in the pediatric patient: Past, present, and future. Neurooncol Pract (2014) 0.80
Tumor cell migration is not influenced by p21 in colon carcinoma cell lines after irradiation with X-ray or (12)C heavy ions. Radiat Environ Biophys (2010) 0.80
Regulation of ionizing radiation-induced adhesion of breast cancer cells to fibronectin by alpha5beta1 integrin. Radiat Res (2014) 0.80
Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging. Mol Imaging Biol (2009) 0.79
Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo. Chin J Cancer (2013) 0.79
Lentivirus-mediated Nox4 shRNA invasion and angiogenesis and enhances radiosensitivity in human glioblastoma. Oxid Med Cell Longev (2014) 0.78
Molecular targets for radiation oncology in prostate cancer. Front Oncol (2011) 0.78
Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion. Cell Mol Neurobiol (2012) 0.78
Phenotypic Transition as a Survival Strategy of Glioma. Neurol Med Chir (Tokyo) (2016) 0.78
Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther (2016) 0.77
Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model. Radiat Oncol (2015) 0.77
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells. Onco Targets Ther (2014) 0.77
Current status and future directions of anti-angiogenic therapy for gliomas. Neuro Oncol (2015) 0.77
Low-dose photon irradiation alters cell differentiation via activation of hIK channels. Pflugers Arch (2014) 0.77
MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells. Inflammopharmacology (2012) 0.77
Elevated cell invasion in a tumor sphere culture of RSV-M mouse glioma cells. Neurol Med Chir (Tokyo) (2014) 0.77
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma. Front Cell Neurosci (2015) 0.77
Proton beam irradiation stimulates migration and invasion of human U87 malignant glioma cells. J Radiat Res (2013) 0.77
Role of proteases in pancreatic carcinoma. World J Surg (2005) 0.77
Radiation oncology in vitro: trends to improve radiotherapy through molecular targets. Biomed Res Int (2014) 0.76
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer (2017) 0.76
The microtubule stabilizer patupilone counteracts ionizing radiation-induced matrix metalloproteinase activity and tumor cell invasion. Radiat Oncol (2013) 0.76
BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells. Oncotarget (2016) 0.76
Subventricular zones: new key targets for glioblastoma treatment. Radiat Oncol (2017) 0.75
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin. Proc Natl Acad Sci U S A (2016) 0.75
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget (2016) 0.75
XuefuZhuyu Tang exerts antitumor effects by inhibiting glioma cell metastasis and invasion via regulating tumor microenvironment. Onco Targets Ther (2016) 0.75
Radiosensitization of human glioma cells by tamoxifen is associated with the inhibition of PKC-ι activity in vitro. Oncol Lett (2015) 0.75
Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma. Oncotarget (2017) 0.75
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov. Radiat Oncol (2017) 0.75
Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model. Br J Cancer (2017) 0.75
The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required. Int J Oncol (2017) 0.75
Selective inhibition of EGFR downstream signaling reverses the irradiation-enhanced migration of HNSCC cells. Am J Cancer Res (2015) 0.75
Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells. Cancer Biol Ther (2016) 0.75
Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells. Int J Nanomedicine (2014) 0.75
Bacitracin Inhibits the Migration of U87-MG Glioma Cells via Interferences of the Integrin Outside-in Signaling Pathway. J Korean Neurosurg Soc (2016) 0.75
Identifying and Targeting the Cause of Cancer is Needed to Cure Cancer. Oncol Ther (2016) 0.75
Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci (2016) 0.75
IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma. Oncotarget (2017) 0.75
Starvation after Cobalt-60 γ-Ray Radiation Enhances Metastasis in U251 Glioma Cells by Regulating the Transcription Factor SP1. Int J Mol Sci (2016) 0.75
Differential Superiority of Heavy Charged-Particle Irradiation to X-Rays: Studies on Biological Effectiveness and Side Effect Mechanisms in Multicellular Tumor and Normal Tissue Models. Front Oncol (2016) 0.75
AEG-1 knockdown in colon cancer cell lines inhibits radiation-enhanced migration and invasion in vitro and in a novel in vivo zebrafish model. Oncotarget (2016) 0.75
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell Int (2017) 0.75
A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer. Biomedicine (Taipei) (2017) 0.75
Anterior opercular cortex lesions cause dissociated lower cranial nerve palsies and anarthria but no aphasia: Foix-Chavany-Marie syndrome and "automatic voluntary dissociation" revisited. J Neurol (1993) 3.70
Glutathione, oxidative stress and neurodegeneration. Eur J Biochem (2000) 3.11
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene (2006) 2.82
Cholesterol and Alzheimer's disease: is there a link? Neurology (2001) 2.79
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med (2003) 2.60
Cerebellar encephalitis in adults. J Neurol (1993) 2.30
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med (1995) 2.08
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
Differential effects of central verses peripheral vision on egocentric and exocentric motion perception. Exp Brain Res (1973) 1.98
Letter: Unusual cardiac and neurological reactions to narcotics. Lancet (1973) 1.90
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem (2000) 1.78
CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science (2000) 1.77
Visual control of arm movement in Parkinson's disease. Mov Disord (1994) 1.69
Turnover of protein-bound phosphorylserine in membrane preparations from ox brain catalysed by intrinsic kinase and phosphatase activity. Biochem J (1971) 1.68
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol (2010) 1.63
Moving visual scenes influence the apparent direction of gravity. Science (1972) 1.62
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology (2002) 1.60
Protein kinase activity in membrane preparations from ox brain. Stimulation of intrinsic activity by adenosine 3':5'-cyclic monophosphate. Biochem J (1973) 1.59
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology (2005) 1.52
Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia. Brain (1979) 1.51
Expression and functional activity of osteoprotegerin in human malignant gliomas. Acta Neuropathol (2003) 1.49
Short rib-polydactyly (SRP) syndromes, types Majewski and Saldino-Noonan. Z Kinderheilkd (1974) 1.48
The significance of proprioception on postural stabilization as assessed by ischemia. Brain Res (1984) 1.48
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol (2002) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 1.45
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Cerebellar ataxia in ataxic hemiparesis? A kinematic and EMG analysis. Mov Disord (1993) 1.43
Mechanisms underlying recovery of eye-head coordination following bilateral labyrinthectomy in monkeys. Exp Brain Res (1973) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry (1993) 1.41
MRI features of primary central nervous system lymphomas at presentation. Neurology (2001) 1.40
Elevated levels of fibronectin in the CSF: what do they signify? J Neurol Sci (1992) 1.38
[Neuronal protection in neurologic diseases?]. Nervenarzt (1994) 1.38
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol (1999) 1.36
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol (2001) 1.33
APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett (1998) 1.32
On the role of vestibular, visual and somatosensory information for dynamic postural control in humans. Prog Brain Res (1988) 1.31
Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res (1999) 1.31
Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech (2001) 1.30
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
The development toward stereotypic arm kinematics during reaching in the first 3 years of life. Exp Brain Res (1997) 1.29
Stimulation by cyclic AMP of intrinsic protein kinase activity in ox brain membrane preparations. Nature (1970) 1.29
Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol (1999) 1.28
Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol (1995) 1.26
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene (2003) 1.26
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene (2000) 1.26
Early stabilization of human posture after a sudden disturbance: influence of rate and amplitude of displacement. Exp Brain Res (1984) 1.25
Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer (1998) 1.25
Comparing explorative saccade and flicker training in hemianopia: a randomized controlled study. Neurology (2009) 1.25
A defect of kinesthesia in Parkinson's disease. Mov Disord (1995) 1.23
Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain (1998) 1.23
Breaking symmetry: the marine environment, prey size, and the evolution of asymmetry in cetacean skulls. Anat Rec (Hoboken) (2007) 1.22
Variability of postural "reflexes" in humans. Exp Brain Res (1983) 1.22
Some methods and parameters of body sway quantification and their neurological applications. Arch Psychiatr Nervenkr (1970) (1980) 1.22
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
The effect of lateral head tilt on horizontal postrotatory nystagmus I and II and the Purkinje effect. Acta Otolaryngol (1985) 1.20
The development of goal-directed reaching in infants: hand trajectory formation and joint torque control. Exp Brain Res (1995) 1.20
Classical conditioning after cerebellar lesions in humans. Behav Neurosci (1993) 1.19
Characteristic alterations of long-loop "reflexes" in patients with Friedreich's disease and late atrophy of the cerebellar anterior lobe. J Neurol Neurosurg Psychiatry (1984) 1.19
Motion habituation: inverted self-motion perception and optokinetic after-nystagmus. Exp Brain Res (1974) 1.19
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache (1991) 1.18
Functional coupling of human cortical sensorimotor areas during bimanual skill acquisition. Brain (1999) 1.18
Gluteal compartment syndrome due to rhabdomyolysis after heroin abuse. Neurology (1997) 1.17
Large scale preparation of a crude membrane fraction from ox brain. J Neurochem (1969) 1.16
Violence and mental illness. Br Med J (Clin Res Ed) (1984) 1.16
Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci U S A (1999) 1.15
Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors. J Neuropathol Exp Neurol (2000) 1.15
The origin of contraversive pushing: evidence for a second graviceptive system in humans. Neurology (2000) 1.14
Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2. J Neurosci (2001) 1.14
Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene (2009) 1.13
Tonic pupil, areflexia, and segmental anhidrosis: two additional cases of Ross syndrome and review of the literature. J Neurol (1992) 1.13
Postural sway in normals and atactic patients: analysis of the stabilising and destabilizing effects of vision. Agressologie (1976) 1.12
HSV-2 sacral radiculitis (Elsberg syndrome). Neurology (2004) 1.12